Your browser doesn't support javascript.
loading
Therapeutic administration of etoposide coincides with reduced systemic HMGB1 levels in macrophage activation syndrome.
Palmblad, Karin; Schierbeck, Hanna; Sundberg, Erik; Horne, Anna-Carin; Erlandsson Harris, Helena; Henter, Jan-Inge; Andersson, Ulf.
Afiliação
  • Palmblad K; Department of Women's and Children's Health, Karolinska Institute at Karolinska University Hospital, 17176, Stockholm, Sweden.
  • Schierbeck H; Department of Women's and Children's Health, Karolinska Institute at Karolinska University Hospital, 17176, Stockholm, Sweden.
  • Sundberg E; Department of Women's and Children's Health, Karolinska Institute at Karolinska University Hospital, 17176, Stockholm, Sweden.
  • Horne AC; Department of Women's and Children's Health, Karolinska Institute at Karolinska University Hospital, 17176, Stockholm, Sweden.
  • Erlandsson Harris H; Rheumatology Unit, Department of Medicine, Karolinska Institute at Karolinska University Hospital, 17176, Stockholm, Sweden.
  • Henter JI; Childhood Cancer Research Unit, Department of Women׳‬s and Children׳‬s Health, Karolinska Institute, 17177, Stockholm, Sweden.
  • Andersson U; Theme of Children, Karolinska University Hospital, 17176, Solna, Stockholm, Sweden.
Mol Med ; 27(1): 48, 2021 05 11.
Article em En | MEDLINE | ID: mdl-33975537
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Biomarcadores / Proteína HMGB1 / Etoposídeo / Síndrome de Ativação Macrofágica Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Biomarcadores / Proteína HMGB1 / Etoposídeo / Síndrome de Ativação Macrofágica Idioma: En Ano de publicação: 2021 Tipo de documento: Article